{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:24:41Z","timestamp":1786487081185,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274187"],"award-info":[{"award-number":["82274187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Young Elite Scientists Sponsorship Program by CACM","award":["CACM-(2023-QNRC2-A01)"],"award-info":[{"award-number":["CACM-(2023-QNRC2-A01)"]}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"crossref","award":["2023NSFSC0687"],"award-info":[{"award-number":["2023NSFSC0687"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Association for Pharmaceutical Education 2022 Major Scientific Problems and Pharmaceutical Technological Difficulties Research Topics","award":["2022KTZ016"],"award-info":[{"award-number":["2022KTZ016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02245-0","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T03:20:27Z","timestamp":1737948027000},"page":"3006-3021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploration of the Combined Mechanism of Direct and Indirect Effects of Paeoniflorin in the Treatment of Cholestasis"],"prefix":"10.1007","volume":"48","author":[{"given":"Wenwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoguang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"2245_CR1","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/liv.13880","volume":"38","author":"Jordan Goldstein","year":"2018","unstructured":"Goldstein, Jordan, and Cynthia Levy. 2018. Novel and emerging therapies for cholestatic liver diseases. Liver International 38: 1520\u20131535. https:\/\/doi.org\/10.1111\/liv.13880.","journal-title":"Liver International"},{"key":"2245_CR2","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","volume":"62","author":"Ulrich Beuers","year":"2015","unstructured":"Beuers, Ulrich, Michael Trauner, Peter Jansen, and Raoul Poupon. 2015. New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond. Journal of Hepatology 62: S25\u2013S37. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.023.","journal-title":"Journal of Hepatology"},{"key":"2245_CR3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/hep.28932","volume":"65","author":"Sumeyye Samur","year":"2017","unstructured":"Samur, Sumeyye, Matthew Klebanoff, Reiner Banken, Daniel S. Pratt, Rick Chapman, Daniel A. Ollendorf, Anne M. Loos, Kathleen Corey, Chin Hur, and Jagpreet Chhatwal. 2017. Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Hepatology 65: 920\u2013928. https:\/\/doi.org\/10.1002\/hep.28932.","journal-title":"Hepatology"},{"key":"2245_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","volume":"24","author":"Tingting Yang","year":"2019","unstructured":"Yang, Tingting, Ghulam Jilany Khan, Wu. Ziteng, Xue Wang, Luyong Zhang, and Zhenzhou Jiang. 2019. Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases. Drug Discovery Today 24: 112\u2013128. https:\/\/doi.org\/10.1016\/j.drudis.2018.09.007.","journal-title":"Drug Discovery Today"},{"key":"2245_CR5","doi-asserted-by":"publisher","first-page":"156021","DOI":"10.1016\/j.phymed.2024.156021","volume":"134","author":"Xiao Ma","year":"2024","unstructured":"Ma, Xiao, Wenwen Zhang, Yuan Chen, Hu. Qichao, Zexin Wang, Tao Jiang, Yi. Zeng, and Thomas Efferth. 2024. Paeoniflorin inhibited GSDMD to alleviate ANIT-induced cholestasis via pyroptosis signaling pathway. Phytomedicine 134: 156021. https:\/\/doi.org\/10.1016\/j.phymed.2024.156021.","journal-title":"Phytomedicine"},{"key":"2245_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/MOG.0000000000000814","volume":"38","author":"Alix Bruneau","year":"2022","unstructured":"Bruneau, Alix, Adrien Guillot, and Frank Tacke. 2022. Macrophages in cholangiopathies. Current Opinion in Gastroenterology 38: 114\u2013120. https:\/\/doi.org\/10.1097\/MOG.0000000000000814.","journal-title":"Current Opinion in Gastroenterology"},{"key":"2245_CR7","doi-asserted-by":"publisher","unstructured":"Zhuang, Yuan, Mart\u00ed Ortega-Ribera, Prashanth Thevkar Nagesh, Radhika Joshi, Huihui Huang, Yanbo Wang, Adam Zivny, Jeeval Mehta, Samir M. Parikh, and Gyongyi Szabo. 2023. Bile acid\u2013induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000611.","DOI":"10.1097\/HEP.0000000000000611"},{"key":"2245_CR8","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1002\/hep.32027","volume":"74","author":"Vartak Nachiket","year":"2021","unstructured":"Nachiket, Vartak, Dirk Drasdo, Fabian Geisler, R.P.J. Tohru Itoh, Oude Elferink, S.F.J. van de Graaf, John Chiang, et al. 2021. On the Mechanisms of Biliary Flux. Hepatology 74: 3497\u20133512. https:\/\/doi.org\/10.1002\/hep.32027.","journal-title":"Hepatology"},{"key":"2245_CR9","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/ptr.6621","volume":"34","author":"Xiao Ma","year":"2020","unstructured":"Ma, Xiao, Yinxiao Jiang, Wenwen Zhang, Jiabo Wang, Ruilin Wang, Lifu Wang, Shizhang Wei, Jianxia Wen, Haotian Li, and Yanling Zhao. 2020. Natural products for the prevention and treatment of cholestasis: A review. Phytotherapy Research 34: 1291\u20131309. https:\/\/doi.org\/10.1002\/ptr.6621.","journal-title":"Phytotherapy Research"},{"key":"2245_CR10","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.3390\/molecules27238534","volume":"27","author":"Xinyu Deng","year":"2022","unstructured":"Deng, Xinyu, Yubing Li, Xing Li, Zhenpeng Zhang, Shu Dai, Wu. Hefei, Fangling Zhang, et al. 2022. Paeoniflorin Protects against Acetaminophen-Induced Liver Injury in Mice via JNK Signaling Pathway. Molecules 27: 8534. https:\/\/doi.org\/10.3390\/molecules27238534.","journal-title":"Molecules"},{"key":"2245_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.intimp.2010.11.012","volume":"11","author":"Wenjuan Cao","year":"2011","unstructured":"Cao, Wenjuan, Wei Zhang, Jingjing Liu, Yuan Wang, Xuemei Peng, Lu. Daxiang, Renbin Qi, Yanping Wang, and Huadong Wang. 2011. Paeoniflorin improves survival in LPS-challenged mice through the suppression of TNF-\u03b1 and IL-1\u03b2 release and augmentation of IL-10 production. International Immunopharmacology 11: 172\u2013178. https:\/\/doi.org\/10.1016\/j.intimp.2010.11.012.","journal-title":"International Immunopharmacology"},{"key":"2245_CR12","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/jphp.13008","volume":"70","author":"Xiao Ma","year":"2018","unstructured":"Ma, Xiao, Jian-Xia. Wen, Si-Jia. Gao, Xuan He, Peng-Yan. Li, Yu-Xue. Yang, Shi-zhang Wei, Yan-Ling. Zhao, and Xiao-He. Xiao. 2018. Paeonia lactiflora Pall. regulates the NF-\u03baB-NLRP3 inflammasome pathway to alleviate cholestasis in rats. Journal of Pharmacy and Pharmacology 70: 1675\u20131687. https:\/\/doi.org\/10.1111\/jphp.13008.","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"2245_CR13","doi-asserted-by":"publisher","unstructured":"Zhao, Yan-ling, Xiao Ma, Yun Zhu, Zhe Chen, Jiabo Wang, Ruiyu Li, Chang Chen, et al. 2015. Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K\/Akt signaling pathway. Drug Design, Development and Therapy: 5061. https:\/\/doi.org\/10.2147\/DDDT.S90030.","DOI":"10.2147\/DDDT.S90030"},{"key":"2245_CR14","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1097\/HEP.0000000000000041","volume":"77","author":"Liangjun Zhang","year":"2023","unstructured":"Zhang, Liangjun, Lu. Qiong Pan, Haihan Xia Zhang, Junwei Liao, Xiaoxun Zhang, Nan Zhao, et al. 2023. Runt-related transcription factor-1 ameliorates bile acid\u2013induced hepatic inflammation in cholestasis through JAK\/STAT3 signaling. Hepatology 77: 1866\u20131881. https:\/\/doi.org\/10.1097\/HEP.0000000000000041.","journal-title":"Hepatology"},{"key":"2245_CR15","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/bph.15429","volume":"178","author":"Jiaqing Xiang","year":"2021","unstructured":"Xiang, Jiaqing, Guangyan Yang, Chuanrui Ma, Lingling Wei, Wu. Han, Wei Zhang, Xiuhua Tao, et al. 2021. Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPAR\u03b3. British Journal of Pharmacology 178: 2443\u20132460. https:\/\/doi.org\/10.1111\/bph.15429.","journal-title":"British Journal of Pharmacology"},{"key":"2245_CR16","doi-asserted-by":"publisher","first-page":"113432","DOI":"10.1016\/j.jep.2020.113432","volume":"266","author":"Wan Hua","year":"2021","unstructured":"Hua, Wan, Shiyan Zhang, Lu. Qiuxia, Yiran Sun, Shancai Tan, Fang Chen, and Lin Tang. 2021. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice. Journal of Ethnopharmacology 266: 113432. https:\/\/doi.org\/10.1016\/j.jep.2020.113432.","journal-title":"Journal of Ethnopharmacology"},{"key":"2245_CR17","doi-asserted-by":"publisher","first-page":"113914","DOI":"10.1016\/j.fct.2023.113914","volume":"178","author":"Peng Cao","year":"2023","unstructured":"Cao, Peng, Jun Gan, Wu. Sanlan, Hu. Yixin, Bin Xia, Xiaoyue Li, Hongan Zeng, et al. 2023. Molecular mechanisms of hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: Role of FXR and Nrf2 pathways. Food and Chemical Toxicology 178: 113914. https:\/\/doi.org\/10.1016\/j.fct.2023.113914.","journal-title":"Food and Chemical Toxicology"},{"key":"2245_CR18","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.mayocp.2020.01.015","volume":"95","author":"Moira B Hilscher","year":"2020","unstructured":"Hilscher, Moira B., Patrick S. Kamath, and John E. Eaton. 2020. Cholestatic Liver Diseases. Mayo Clinic Proceedings 95: 2263\u20132279. https:\/\/doi.org\/10.1016\/j.mayocp.2020.01.015.","journal-title":"Mayo Clinic Proceedings"},{"key":"2245_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2020.0028","volume":"27","author":"Atsushi Tanaka","year":"2021","unstructured":"Tanaka, Atsushi. 2021. Current understanding of primary biliary cholangitis. Clinical and Molecular Hepatology 27: 1\u201321. https:\/\/doi.org\/10.3350\/cmh.2020.0028.","journal-title":"Clinical and Molecular Hepatology"},{"key":"2245_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s40265-021-01545-7","volume":"81","author":"Sho Hasegawa","year":"2021","unstructured":"Hasegawa, Sho, Masato Yoneda, Yusuke Kurita, Asako Nogami, Yasushi Honda, Kunihiro Hosono, and Atsushi Nakajima. 2021. Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents. Drugs 81: 1181\u20131192. https:\/\/doi.org\/10.1007\/s40265-021-01545-7.","journal-title":"Drugs"},{"key":"2245_CR21","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/hep.26453","volume":"58","author":"Delphine Firrincieli","year":"2013","unstructured":"Firrincieli, Delphine, Silvia Z\u00fa\u00f1iga, Colette Rey, Dominique Wendum, Elisabeth Lasnier, Dominique Rainteau, Thomas Braescu, et al. 2013. Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice. Hepatology 58: 1401\u20131412. https:\/\/doi.org\/10.1002\/hep.26453.","journal-title":"Hepatology"},{"key":"2245_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jcmgh.2021.04.003","volume":"12","author":"Felix Alexander Baier","year":"2021","unstructured":"Baier, Felix Alexander, Daniel S\u00e1nchez-Taltavull, Tural Yarahmadov, Cristina G\u00f3mez. Castell\u00e0, Fadi Jebbawi, Adrian Keogh, Riccardo Tombolini, et al. 2021. Loss of Claudin-3 Impairs Hepatic Metabolism, Biliary Barrier Function, and Cell Proliferation in the Murine Liver. Cellular and Molecular Gastroenterology and Hepatology 12: 745\u2013767. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.04.003.","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"2245_CR23","doi-asserted-by":"publisher","first-page":"176917","DOI":"10.1016\/j.ejphar.2024.176917","volume":"981","author":"Lingjie Meng","year":"2024","unstructured":"Meng, Lingjie, Huijing Lv, Qinghong Kong, Sanhua Li, Nian Jiang, Yu. Changyan, Zhen Duan, Yi. Xiao, and Yun Liu. 2024. The combination of paeoniflorin and metformin synergistically inhibits the progression of liver fibrosis in mice. European Journal of Pharmacology 981: 176917. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176917.","journal-title":"European Journal of Pharmacology"},{"key":"2245_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1911311","volume":"2022","author":"Jun-Fei Li","year":"2022","unstructured":"Li, Jun-Fei., Xiao-Rong. Zheng, Hong-Yan. Zhang, Chang-Ming. Shen, Guo-xin Shen, and Jian-Wei. Jiang. 2022. Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-\u03baB-HIF-2\u03b1-SerpinB3 Pathway. Evidence-Based Complementary and Alternative Medicine 2022: 1\u201311. https:\/\/doi.org\/10.1155\/2022\/1911311.","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"2245_CR25","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41401-020-00510-6","volume":"41","author":"Xue-zhi Yang","year":"2020","unstructured":"Yang, Xue-zhi, and Wei Wei. 2020. CP-25, a compound derived from paeoniflorin: Research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacologica Sinica 41: 1387\u20131394. https:\/\/doi.org\/10.1038\/s41401-020-00510-6.","journal-title":"Acta Pharmacologica Sinica"},{"key":"2245_CR26","doi-asserted-by":"publisher","unstructured":"Yu, Jin-Bo, Zhen-Xiong Zhao, Ran Peng, Li-Bin Pan, Jie Fu, Shu-Rong Ma, Pei Han, et al. 2019. Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin. Frontiers in Pharmacology 10. https:\/\/doi.org\/10.3389\/fphar.2019.00268.","DOI":"10.3389\/fphar.2019.00268"},{"key":"2245_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/03639045.2020.1862178","volume":"47","author":"Chengying Shen","year":"2021","unstructured":"Shen, Chengying, Baode Shen, Junjun Zhu, Jing Wang, Hailong Yuan, and Xiaofang Li. 2021. Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. Drug Development and Industrial Pharmacy 47: 207\u2013214. https:\/\/doi.org\/10.1080\/03639045.2020.1862178.","journal-title":"Drug Development and Industrial Pharmacy"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02245-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:21:10Z","timestamp":1762881670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02245-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2245"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02245-0","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}